Monoclonal antibody hNM01 in HIV-infected patients: a phase I study
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 31, 45-47
- https://doi.org/10.1016/j.jcv.2004.09.003
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1AIDS, 2002
- A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor sourceJournal of General Virology, 2001
- Virolysis andIn VitroNeutralization of HIV-1 by Humanized Monoclonal Antibody hNM-01Hybridoma, 2000
- Mutations of the HIV Type 1 V3 Loop under Selection Pressure with Neutralizing Monoclonal Antibody NM-01AIDS Research and Human Retroviruses, 1997
- Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected PatientsJAMA, 1993
- Complement-Dependent Virolysis of HIV-1 with Monoclonal Antibody NM-01AIDS Research and Human Retroviruses, 1993
- Humanised monoclonal antibody therapy for rheumatoid arthritisThe Lancet, 1992
- A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proceedings of the National Academy of Sciences, 1989